Books > Social sciences > Sociology, social studies > Social issues > Illness & addiction: social aspects > AIDS: social aspects
|
Buy Now
'Ending AIDS' in the Age of Biopharmaceuticals - The Individual, the State and the Politics of Prevention (Hardcover)
Loot Price: R4,134
Discovery Miles 41 340
|
|
'Ending AIDS' in the Age of Biopharmaceuticals - The Individual, the State and the Politics of Prevention (Hardcover)
Series: Routledge Studies in the Sociology of Health and Illness
Expected to ship within 12 - 17 working days
|
This book considers the change in rhetoric surrounding the
treatment of AIDS from one of crisis to that of 'ending AIDS'.
Exploring what it means to 'end AIDS' and how responsibility is
framed in this new discourse, the author considers the tensions
generated between the individual and the state in terms of notions
such as risk, responsibility and prevention. Based on analyses
public health promotions in the UK and the US, HIV prevention
science and engaging with the work of Foucault, this volume argues
that the discourse of 'ending AIDS' implies a tension-filled space
in which global principles and values may clash with localised
needs, values and concerns; in which evidence-based policies strive
for hegemony over local, tacit and communal regimes of knowledge;
and in which desires compete with national and international ideas
about what is best for the individual in the name of 'ending AIDS'
writ large. As such, it will appeal to scholars of sociology and
media studies with interests in the sociology of medicine and
health, medical communication and health policy.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.